Search

everythinglearnresearchcommunity

for

Search:↓

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Nonmelanoma skin cancers have higher levels of certain osteopontin variants than normal skin.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

The conclusion is that Pigmented Epithelioid Melanocytoma can start from hair follicle stem cells or from a mole on the skin.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

HPV8 E6 gene causes growth of certain skin stem cells.

LSD1 is essential for healthy skin development and creating the skin's protective barrier.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

The skin lesion was diagnosed as a matrical cyst with unusual features.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

Most U.S. keratinocyte carcinoma patients are older white males living in urban areas.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Testosterone metabolism in balding scalp cells may not be the main cause of hair loss.

Recent findings advanced understanding of cancer mechanisms and potential treatments.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Enlarged sweat gland ducts may indicate scarring hair loss.